Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Thrombocytopenia? 298 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Thrombocytopenia have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 3.3% of all adverse event reports for CYCLOBENZAPRINE.

298
Reports of Thrombocytopenia with CYCLOBENZAPRINE
3.3%
of all CYCLOBENZAPRINE reports
108
Deaths
14
Hospitalizations

How Dangerous Is Thrombocytopenia From CYCLOBENZAPRINE?

Of the 298 reports, 108 (36.2%) resulted in death, 14 (4.7%) required hospitalization, and 9 (3.0%) were considered life-threatening.

Is Thrombocytopenia Listed in the Official Label?

Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for CYCLOBENZAPRINE.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Hypotension (769)

What Other Drugs Cause Thrombocytopenia?

DEXAMETHASONE (5,873) RITUXIMAB (4,810) CYCLOPHOSPHAMIDE (4,669) LENALIDOMIDE (4,584) CARBOPLATIN (4,483) METHOTREXATE (3,865) DOXORUBICIN (3,638) ETOPOSIDE (3,085) VINCRISTINE (2,940) OXALIPLATIN (2,886)

Which CYCLOBENZAPRINE Alternatives Have Lower Thrombocytopenia Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Thrombocytopenia Reports All Drugs Causing Thrombocytopenia CYCLOBENZAPRINE Demographics